Comprehensive molecular analysis of immortalization hallmarks in thyroid cancer reveals new prognostic markers

Cristina Montero‐Conde(Spanish National Cancer Research Centre), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Luis J. Leandro‐García(Spanish National Cancer Research Centre), María Currás-Freixes(Spanish National Cancer Research Centre), Guillermo Pita(Spanish National Cancer Research Centre), Eduardo Gil(Spanish National Centre for Cardiovascular Research), Juan C. Galofré(Instituto de Salud Pública de Navarra), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), Rafael Torres‐Pérez(Spanish National Cancer Research Centre), Carles Zafón(Vall d'Hebron Hospital Universitari), Anna González‐Neira(Spanish National Cancer Research Centre), Laura García‐Tobar(Clinica Universidad de Navarra), Garcilaso Riesco‐Eizaguirre(Universidad Francisco de Vitoria), Sonsoles Guadalix(Research Institute Hospital 12 de Octubre), Sergio Ruiz‐Llorente(Consejo Superior de Investigaciones Científicas), María Monteagudo(Spanish National Cancer Research Centre), Diego Megı́as(Spanish National Cancer Research Centre), Manuel Pérez‐Martínez(Spanish National Cancer Research Centre), Patricia González‐García(Spanish National Cancer Research Centre), Paula Martínez(Spanish National Cancer Research Centre), Sandra Rodríguez(Spanish National Cancer Research Centre), Natalia Martínez‐Puente(Instituto de Salud Carlos III), Veronika Mančíková(Centro de Biología Molecular Severo Ochoa), Alberto Cascón(Spanish National Cancer Research Centre), Marı́a A. Blasco(Spanish National Cancer Research Centre), Mireia Jordà(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol), Francisco Moya(Spanish National Cancer Research Centre), Rocío Letón, Ángel M. Martínez‐Montes(Spanish National Cancer Research Centre), Eduardo Caleiras(Spanish National Cancer Research Centre)
Clinical and Translational Medicine
August 1, 2022
Cited by 21


Related Papers